Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Malignancy-associated hypercalcemia].

K Yamaguchi1

  • 1Growth Factor Division, National Cancer Center Research Institute, Tokyo, Japan.

Gan to Kagaku Ryoho. Cancer & Chemotherapy
|March 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The development of hypercalcemia in a patient with an ovarian tumor producing parathyroid hormone-related protein.

Cancer·1992
Same author

Pancreatic carcinoma associated with chronic calcifying pancreatitis.

International journal of pancreatology : official journal of the International Association of Pancreatology·1992
Same author

[Alteration of oxygen extraction and blood flow in various organs under acute hypoxia].

Nihon Kyobu Shikkan Gakkai zasshi·1992
Same author

Treatment of hairy cell leukemia with deoxycoformycin (YK-176). The Deoxycoformycin (YK-176) Study Group.

Japanese journal of clinical oncology·1992
Same author

Thyroxine-binding globulin variant (TBG-Kumamoto): identification of a point mutation and genotype analysis of its family.

Endocrinologia japonica·1992
Same author

[Life and fatigue of the shiftworkers with two days off in the weekend].

Sangyo igaku. Japanese journal of industrial health·1992

Humoral hypercalcemia of malignancy (HHM) is often caused by parathyroid hormone-related protein (PTHrP). PTHrP, produced by tumors, explains the clinical findings in HHM patients.

Area of Science:

  • Oncology
  • Endocrinology
  • Molecular Biology

Context:

  • Hypercalcemia is a common complication in cancer patients, presenting as either bone metastasis-induced or humoral hypercalcemia of malignancy (HHM).
  • HHM involves the secretion of factors by tumors that elevate calcium levels.

Purpose:

  • To identify the specific humoral factor responsible for HHM.
  • To elucidate the role of parathyroid hormone-related protein (PTHrP) in malignancy-associated hypercalcemia.

Summary:

  • Parathyroid hormone-related protein (PTHrP) was isolated from a lung cancer cell line.
  • PTHrP exhibits parathyroid hormone-like activity and its mRNA structure was identified.
  • The biological activity of PTHrP aligns with clinical and laboratory observations in HHM patients.

Related Experiment Videos

Impact:

  • PTHrP is recognized as the primary factor causing HHM.
  • Understanding PTHrP's role can lead to targeted therapies for cancer-related hypercalcemia.
  • This research clarifies a significant paraneoplastic syndrome in oncology.